The effects of antidepressants on the hypothalamic-pituitary-adrenal axis

Brittany L. Mason, Carmine M. Pariante

Research output: Contribution to journalReview article

70 Citations (Scopus)

Abstract

Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis has been found in some psychiatric disorders, especially in older patients with severe depression. Altered feedback inhibition, as demonstrated by increased circulating cortisol and nonsuppresssion of cortisol following administration of dexamethasone, may be to blame. Two glucocorticoid receptors control the HPA axis, the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). MR regulates normal HPA fluctuations and the GR regulates in times of stress. Long-term antidepressant treatment in humans has been shown to upregulate both GR and MR in the brain, whereas short-term treatment has been shown to downregulate GR and MR. After 6-9 weeks of treatment GR function returns to normal, and the MR stays upregulated. Chronic antidepressant treatment in rodents has been shown to reduce HPA activity, even in the absence of GR or MR upregulation. These effects of antidepressants on HPA regulation may be attributed in part to regulation of the multidrug resistance protein transporter, P-glycoprotein. Finding relationships between antidepressant action and HPA regulation leads to the conclusion that the disruption of the HPA may be more a contributing factor to depression than other biological abnormalities.

Original languageEnglish (US)
Pages (from-to)603-608
Number of pages6
JournalDrug News and Perspectives
Volume19
Issue number10
DOIs
StatePublished - Dec 1 2006

Fingerprint

Glucocorticoid Receptors
Mineralocorticoid Receptors
Antidepressive Agents
Hydrocortisone
Up-Regulation
P-Glycoproteins
P-Glycoprotein
Therapeutics
Dexamethasone
Psychiatry
Rodentia
Down-Regulation
Brain

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

The effects of antidepressants on the hypothalamic-pituitary-adrenal axis. / Mason, Brittany L.; Pariante, Carmine M.

In: Drug News and Perspectives, Vol. 19, No. 10, 01.12.2006, p. 603-608.

Research output: Contribution to journalReview article

@article{ab5ffc9e07e14f0983fd5be8fe15e03b,
title = "The effects of antidepressants on the hypothalamic-pituitary-adrenal axis",
abstract = "Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis has been found in some psychiatric disorders, especially in older patients with severe depression. Altered feedback inhibition, as demonstrated by increased circulating cortisol and nonsuppresssion of cortisol following administration of dexamethasone, may be to blame. Two glucocorticoid receptors control the HPA axis, the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). MR regulates normal HPA fluctuations and the GR regulates in times of stress. Long-term antidepressant treatment in humans has been shown to upregulate both GR and MR in the brain, whereas short-term treatment has been shown to downregulate GR and MR. After 6-9 weeks of treatment GR function returns to normal, and the MR stays upregulated. Chronic antidepressant treatment in rodents has been shown to reduce HPA activity, even in the absence of GR or MR upregulation. These effects of antidepressants on HPA regulation may be attributed in part to regulation of the multidrug resistance protein transporter, P-glycoprotein. Finding relationships between antidepressant action and HPA regulation leads to the conclusion that the disruption of the HPA may be more a contributing factor to depression than other biological abnormalities.",
author = "Mason, {Brittany L.} and Pariante, {Carmine M.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1358/dnp.2006.19.10.1068007",
language = "English (US)",
volume = "19",
pages = "603--608",
journal = "Drug News and Perspectives",
issn = "0214-0934",
publisher = "Prous Science",
number = "10",

}

TY - JOUR

T1 - The effects of antidepressants on the hypothalamic-pituitary-adrenal axis

AU - Mason, Brittany L.

AU - Pariante, Carmine M.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis has been found in some psychiatric disorders, especially in older patients with severe depression. Altered feedback inhibition, as demonstrated by increased circulating cortisol and nonsuppresssion of cortisol following administration of dexamethasone, may be to blame. Two glucocorticoid receptors control the HPA axis, the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). MR regulates normal HPA fluctuations and the GR regulates in times of stress. Long-term antidepressant treatment in humans has been shown to upregulate both GR and MR in the brain, whereas short-term treatment has been shown to downregulate GR and MR. After 6-9 weeks of treatment GR function returns to normal, and the MR stays upregulated. Chronic antidepressant treatment in rodents has been shown to reduce HPA activity, even in the absence of GR or MR upregulation. These effects of antidepressants on HPA regulation may be attributed in part to regulation of the multidrug resistance protein transporter, P-glycoprotein. Finding relationships between antidepressant action and HPA regulation leads to the conclusion that the disruption of the HPA may be more a contributing factor to depression than other biological abnormalities.

AB - Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis has been found in some psychiatric disorders, especially in older patients with severe depression. Altered feedback inhibition, as demonstrated by increased circulating cortisol and nonsuppresssion of cortisol following administration of dexamethasone, may be to blame. Two glucocorticoid receptors control the HPA axis, the mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR). MR regulates normal HPA fluctuations and the GR regulates in times of stress. Long-term antidepressant treatment in humans has been shown to upregulate both GR and MR in the brain, whereas short-term treatment has been shown to downregulate GR and MR. After 6-9 weeks of treatment GR function returns to normal, and the MR stays upregulated. Chronic antidepressant treatment in rodents has been shown to reduce HPA activity, even in the absence of GR or MR upregulation. These effects of antidepressants on HPA regulation may be attributed in part to regulation of the multidrug resistance protein transporter, P-glycoprotein. Finding relationships between antidepressant action and HPA regulation leads to the conclusion that the disruption of the HPA may be more a contributing factor to depression than other biological abnormalities.

UR - http://www.scopus.com/inward/record.url?scp=34247635745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247635745&partnerID=8YFLogxK

U2 - 10.1358/dnp.2006.19.10.1068007

DO - 10.1358/dnp.2006.19.10.1068007

M3 - Review article

C2 - 17299602

AN - SCOPUS:34247635745

VL - 19

SP - 603

EP - 608

JO - Drug News and Perspectives

JF - Drug News and Perspectives

SN - 0214-0934

IS - 10

ER -